Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.
about
Pharmacokinetics and safety of olodaterol administered with the Respimat Soft Mist inhaler in subjects with impaired hepatic or renal function.Olodaterol for the treatment of asthma.Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers.Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.Comparison of plasma pharmacokinetics of Tanreqing solution between intratracheal aerosolization and intravenous injection in rats.Uncovering the regional localization of inhaled salmeterol retention in the lung.
P2860
Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Investigating pulmonary and sy ...... tion pharmacokinetic approach.
@ast
Investigating pulmonary and sy ...... tion pharmacokinetic approach.
@en
type
label
Investigating pulmonary and sy ...... tion pharmacokinetic approach.
@ast
Investigating pulmonary and sy ...... tion pharmacokinetic approach.
@en
prefLabel
Investigating pulmonary and sy ...... tion pharmacokinetic approach.
@ast
Investigating pulmonary and sy ...... tion pharmacokinetic approach.
@en
P2093
P2860
P356
P1476
Investigating pulmonary and sy ...... ation pharmacokinetic approach
@en
P2093
Alexander Staab
Benjamin Weber
Charlotte Kloft
Christina Kunz
Stephan Formella
P2860
P304
P356
10.1111/BCP.12780
P407
P577
2016-02-17T00:00:00Z